Sifrol



Indications and Reactions:

Role Indications Reactions
Primary
Parkinson's Disease 52.1%
Restless Legs Syndrome 24.0%
Hypertension 4.4%
Depression 2.6%
Schizoaffective Disorder 2.4%
Parkinsonism 1.8%
Pain 1.6%
Asthma 1.2%
Diabetes Mellitus 1.2%
Maternal Exposure During Pregnancy 1.2%
Back Pain 1.0%
Bipolar Disorder 1.0%
Benign Prostatic Hyperplasia 0.8%
Colitis Collagenous 0.8%
Constipation 0.8%
Hypercholesterolaemia 0.8%
Progressive Supranuclear Palsy 0.8%
Anaemia 0.6%
Cardiovascular Disorder 0.6%
Coronary Artery Disease 0.6%
Death 12.7%
Suicide Attempt 11.9%
Somnolence 9.5%
Vomiting 7.1%
Pathological Gambling 6.3%
Weight Increased 4.8%
Completed Suicide 4.0%
Oedema Peripheral 4.0%
Parkinson's Disease 4.0%
Renal Failure 4.0%
Tremor 4.0%
Cardiac Failure 3.2%
General Physical Health Deterioration 3.2%
Nausea 3.2%
Overdose 3.2%
Stereotypy 3.2%
Syncope 3.2%
Tachycardia 3.2%
Visual Impairment 3.2%
Gallbladder Operation 2.4%
Secondary
Parkinson's Disease 53.7%
Drug Use For Unknown Indication 8.1%
Psychotic Disorder 5.6%
Restless Legs Syndrome 5.6%
Pain 5.0%
Depression 3.9%
Hypertension 2.4%
Extrapyramidal Disorder 1.9%
Cardiovascular Disorder 1.7%
Bipolar Disorder 1.6%
Constipation 1.6%
Influenza 1.5%
Movement Disorder 1.2%
Diabetes Mellitus 1.1%
Anxiety Disorder 1.0%
Parkinsonism 1.0%
Prophylactic Chemotherapy 1.0%
Anaemia 0.7%
Epilepsy 0.7%
Infection Prophylaxis 0.7%
Restlessness 9.9%
Pulmonary Embolism 9.1%
Dyskinesia 8.3%
Impulse-control Disorder 6.6%
Pre-existing Condition Improved 6.6%
Weight Increased 5.8%
Oedema Peripheral 5.0%
Vomiting 5.0%
Pathological Gambling 4.1%
Sexual Abuse 4.1%
Somnolence 4.1%
Suicidal Ideation 4.1%
Withdrawal Syndrome 4.1%
Loss Of Consciousness 3.3%
Nausea 3.3%
Overdose 3.3%
Parkinson's Disease 3.3%
Restless Legs Syndrome 3.3%
Syncope 3.3%
Tetany 3.3%
Concomitant
Parkinson's Disease 31.1%
Product Used For Unknown Indication 20.0%
Drug Use For Unknown Indication 8.0%
Hypertension 6.9%
Restless Legs Syndrome 6.3%
Chronic Obstructive Pulmonary Disease 3.2%
Polyneuropathy Alcoholic 2.5%
Rheumatoid Arthritis 2.4%
Depression 2.3%
Pain 2.0%
Tremor 1.9%
Coronary Artery Disease 1.8%
Osteoporosis 1.8%
Relapsing-remitting Multiple Sclerosis 1.8%
Prophylaxis 1.6%
Diabetes Mellitus 1.5%
Hypothyroidism 1.3%
Pulmonary Embolism 1.3%
Atrial Fibrillation 1.2%
Type 2 Diabetes Mellitus 1.2%
Progressive Multifocal Leukoencephalopathy 11.0%
Parkinson's Disease 9.1%
Syncope 6.5%
Pyrexia 5.8%
Speech Disorder 5.2%
Vomiting 5.2%
Weight Decreased 5.2%
Dehydration 4.5%
Haematuria 4.5%
Malaise 4.5%
Death 3.9%
Dyspnoea 3.9%
International Normalised Ratio Increased 3.9%
Myocardial Infarction 3.9%
Respiratory Failure 3.9%
Sepsis 3.9%
Stress 3.9%
Tremor 3.9%
Urinary Tract Infection 3.9%
Mitral Valve Incompetence 3.2%
Interacting
Parkinson's Disease 46.4%
Drug Use For Unknown Indication 17.9%
Depression 7.1%
Hypercholesterolaemia 7.1%
Oesophagitis 7.1%
Osteopenia 7.1%
Restless Legs Syndrome 7.1%
Parkinson's Disease 30.0%
Pathological Gambling 30.0%
Supraventricular Tachycardia 20.0%
Tachycardia Paroxysmal 10.0%
Tremor 10.0%